Medical CBD Program Will Bring Missouri Millions

CBD cannabis plants are a secret market growing to $2.1 billion by 2020.

By: Cecil King

Medical CBD Will Bring Missouri Millions

The US domestic cannabidiol (CBD) market is “a secret emerging market” poised to grow into a $2.1 billion market by 2020, says Sean Murphy, publisher of the Hemp Business Journal.

Murphy’s Hemp Business Journal CBD Report details how the CBD market in the US is growing 30 percent per year. In Missouri, prohibitionist laws block the economic and scientific potential of this emerging market.

CBD is one of the most important healing substances of the cannabis plant with a strong anti-inflammatory effect and without a psychotropic (narcotic) effect. CBD has been used to treat many human diseases including rare forms of epilepsy such as Dravet Syndrome and Lennox-Gastaut Syndrome that do not respond to traditional pharmaceutical drugs.

The pioneering neuroscientist Dr. Raphel Mechoulam discovered tetrahydrocannabinol (THC), the other major molecular component in cannabis, and studied the effect of both compounds on the mammalian endocannabinoid system since the early 1960s.

Mechoulam has come to the scientific conclusion that using CBD to stimulate “endocannabinoid activity may have therapeutic potential in almost all diseases affecting humans.”

Murphy makes the distinction in his comprehensive CBD report how cannabidiol is classified by state laws across the US. CBD can be extracted from cannabis plants grown as “marijuana” and cannabis plants grown as “industrial hemp”. Even though both plants are technically “cannabis” and CBD is derived from both, beneficial terpenes and flavinoids may be present in CBD products derived from the flowers and upper leaves of marijuana plants as opposed to the stalks and stems of industrial hemp.

In 2014, Missouri passed HB 2238, which creates a legal right for a small number of patients to obtain, possess, and use “hemp extracts” in limited circumstances. The law defines a “hemp extract” as a preparation of cannabis that contains at least 5% CBD and no more than 0.3% THC.

Cannabis plants grown in Missouri are derived from marijuana strains bred for CBD oil production as opposed to those designated for the industrial hemp market.

Only Missouri patients with a seizure disorder and a recommendation from a neurologist are eligible to obtain a “hemp registration card,” which entitles them to access and legal protections. Patients are allowed to purchase hemp extracts from two Missouri state-regulated “cannabidiol oil care centers.”

Noah’s Arc Foundation Missouri
PO Box 4451, Chesterfield, MO 63006
Website: www.nafmo.org

BeLeaf Company
13378 Lakefront Drive
Earth City, MO 63045
Website: www.beleafco.com

Only neurologists who are licensed in Missouri may issue a written recommendation to a patient to threat intractable epilepsy with CBD oil. Many Missouri neurologists are hesitant to recommend CBD oil to their patients because they fear is would put their medical license in jeopardy. Federal laws list CBD oil as a controlled substance with no medical application.

Cannabis activists across Missouri are gathering signatures to bring a medical cannabis bill to voters in the fall of 2018. New Approach Missouri’s initiative will expand the CBD market in Missouri and allow all forms of cannabis to be used for medical purposes.